Literature DB >> 2622760

Sensitization of articular afferents to mechanical stimuli by bradykinin.

V Neugebauer1, H G Schaible, R F Schmidt.   

Abstract

In 18 cats anaesthetized with alpha-chloralose, we recorded from thin myelinated and unmyelinated articular afferents of the medial articular nerve of the knee joint. Bradykinin was injected intra-arterially close to the knee, alone and in combination with prostaglandin E2 (PGE2), and changes of the responses of single afferents to movements of the knee were monitored. Bradykinin changed the mechanosensitivity in 20 of 28 afferents inducing movement sensitivity in initially unresponsive units, lowering the threshold for movements in high-threshold afferents and/or enhancing pre-existing responses to innocuous and/or noxious joint movements in low and high threshold units. Also the application of PGE2 and bradykinin within a short interval sensitized the majority of these afferents, and in about 50% of the afferents the effect of the combination was superior to those induced by the single substances. We conclude that the inflammatory mediator bradykinin is able to sensitize articular afferents for movement stimuli and that PGE2 may enhance this effect. It is suggested that in arthritis inflammatory mediators act synergistically in the initiation and stabilization of the increased mechanosensitivity of slowly conducting articular afferents.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2622760     DOI: 10.1007/bf00370884

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  22 in total

Review 1.  Prostaglandins and leukotrienes as inflammatory mediators.

Authors:  J A Salmon; G A Higgs
Journal:  Br Med Bull       Date:  1987-04       Impact factor: 4.291

Review 2.  Mediators of rheumatoid arthritis.

Authors:  B Henderson; E R Pettipher; G A Higgs
Journal:  Br Med Bull       Date:  1987-04       Impact factor: 4.291

3.  Mechanical sensitivity of group III and IV afferents from posterior articular nerve in normal and inflamed cat knee.

Authors:  P Grigg; H G Schaible; R F Schmidt
Journal:  J Neurophysiol       Date:  1986-04       Impact factor: 2.714

4.  Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine.

Authors:  M Di Rosa; J P Giroud; D A Willoughby
Journal:  J Pathol       Date:  1971-05       Impact factor: 7.996

Review 5.  Pain.

Authors:  R K Lim
Journal:  Annu Rev Physiol       Date:  1970       Impact factor: 19.318

6.  Role of bradykinin in the vascular permeability response induced by carrageenin in rats.

Authors:  S Kumakura; I Kamo; S Tsurufuji
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

7.  Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.

Authors:  L R Steranka; D C Manning; C J DeHaas; J W Ferkany; S A Borosky; J R Connor; R J Vavrek; J M Stewart; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes.

Authors:  J D Levine; W Lau; G Kwiat; E J Goetzl
Journal:  Science       Date:  1984-08-17       Impact factor: 47.728

Review 9.  Peripheral mechanisms of somatic pain.

Authors:  S N Raja; R A Meyer; J N Campbell
Journal:  Anesthesiology       Date:  1988-04       Impact factor: 7.892

10.  Bradykinin-induced modulation of the response behaviour of different types of feline group III and IV muscle receptors.

Authors:  S Mense; H Meyer
Journal:  J Physiol       Date:  1988-04       Impact factor: 5.182

View more
  23 in total

1.  Sustained sensitization and recruitment of rat cutaneous nociceptors by bradykinin and a novel theory of its excitatory action.

Authors:  Y F Liang; B Haake; P W Reeh
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

2.  Attenuation of persistent experimental pancreatitis pain by a bradykinin b2 receptor antagonist.

Authors:  Qingmin Chen; Louis P Vera-Portocarrero; Michael H Ossipov; Marina Vardanyan; Josephine Lai; Frank Porreca
Journal:  Pancreas       Date:  2010-11       Impact factor: 3.327

3.  Voltage-gated calcium channels may be involved in the regulation of the mechanosensitivity of slowly conducting knee joint afferents in rat.

Authors:  Stefan Just; Bernd Heppelmann
Journal:  Exp Brain Res       Date:  2003-04-16       Impact factor: 1.972

4.  The role of PGE2 in the sensitization of mechanoreceptors in normal and inflamed ankle joints of the rat.

Authors:  B D Grubb; G J Birrell; D S McQueen; A Iggo
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

5.  Effects of systemic non-steroidal anti-inflammatory drugs on nociception during tail ischaemia and on reperfusion hyperalgesia in rats.

Authors:  L Gelgor; N Butkow; D Mitchell
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

Review 6.  Basic mechanisms of cough: current understanding and remaining questions.

Authors:  Min-Goo Lee; Bradley J Undem
Journal:  Lung       Date:  2007-12-09       Impact factor: 2.584

Review 7.  Protease-activated receptor 4: a critical participator in inflammatory response.

Authors:  Qiang Fu; Jing Cheng; Yebo Gao; Yonglei Zhang; Xiaobing Chen; Jianguo Xie
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

Review 8.  Ion channels and osteoarthritic pain: potential for novel analgesics.

Authors:  C A Staunton; R Lewis; R Barrett-Jolley
Journal:  Curr Pain Headache Rep       Date:  2013-12

9.  Responses of lateral thalamic neurons to algesic chemical stimulation of the cat knee joint.

Authors:  W D Hutchison; M A Lühn; R F Schmidt
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

10.  Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms.

Authors:  M A Moskowitz; K Nozaki; R P Kraig
Journal:  J Neurosci       Date:  1993-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.